Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 16, 2021

SELL
$98.77 - $132.17 $588,965 - $788,129
-5,963 Closed
0 $0
Q2 2021

Aug 11, 2021

BUY
$109.77 - $165.68 $191,768 - $289,442
1,747 Added 41.44%
5,963 $741,000
Q1 2021

May 06, 2021

SELL
$127.04 - $179.1 $1.32 Million - $1.87 Million
-10,424 Reduced 71.2%
4,216 $644,000
Q4 2020

Feb 09, 2021

BUY
$99.96 - $135.93 $79,768 - $108,472
798 Added 5.77%
14,640 $1.89 Million
Q3 2020

Nov 09, 2020

BUY
$80.32 - $111.8 $172,928 - $240,705
2,153 Added 18.42%
13,842 $1.55 Million
Q2 2020

Aug 04, 2020

BUY
$60.49 - $97.5 $707,067 - $1.14 Million
11,689 New
11,689 $948,000
Q1 2020

May 06, 2020

SELL
$59.04 - $88.81 $794,028 - $1.19 Million
-13,449 Closed
0 $0
Q4 2019

Feb 11, 2020

BUY
$59.49 - $82.78 $800,081 - $1.11 Million
13,449 New
13,449 $1.05 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.14B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Quantitative Systematic Strategies LLC Portfolio

Follow Quantitative Systematic Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.